Xencor (XNCR) Receivables (2013 - 2026)
Xencor's (XNCR) quarterly Receivables came in at $12.0 million in Q1 2026, down 68.24% year-on-year from $37.8 million in Q1 2025, and down 59.04% on a QoQ basis from $29.3 million in Q4 2025.
Xencor (XNCR) Receivables (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Receivables data on file, last reported at $12.0 million in Q1 2026.
- On a quarterly basis, Receivables fell 68.24% year-over-year to $12.0 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 68.24% decrease from a year earlier, with the FY2025 full-year figure at $29.3 million, down 55.97% from the prior year.
- Receivables for Q1 2026 stood at $12.0 million, down from $29.3 million in the prior quarter.
- Over the last five years, Receivables for XNCR reached as high as $93.2 million in Q1 2022 and fell as low as $2.2 million in Q3 2023.
- Historically, Receivables has averaged $34.7 million across 5 years, with a median of $29.3 million in 2025.
- Across the five-year window, Receivables jumped 5328.4% in 2022 and sank 95.1% in 2023, its largest moves.
- Year by year, Receivables stood at $30.3 million in 2022, then retreated by 14.05% to $26.0 million in 2023, then jumped by 155.57% to $66.5 million in 2024, then slumped by 55.97% to $29.3 million in 2025, then plunged by 59.04% to $12.0 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $12.0 million in Q1 2026, $29.3 million in Q4 2025, and $21.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 29.30 Mn |
| Sep 30, 2025 | 21.81 Mn |
| Jun 30, 2025 | 47.55 Mn |
| Mar 31, 2025 | 37.79 Mn |
| Dec 31, 2024 | 66.55 Mn |
| Sep 30, 2024 | 25.87 Mn |
| Jun 30, 2024 | 35.92 Mn |
| Mar 31, 2024 | 22.18 Mn |
| Dec 31, 2023 | 26.04 Mn |
| Sep 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 20.02 Mn |
| Mar 31, 2023 | 19.86 Mn |
| Dec 31, 2022 | 30.30 Mn |
| Sep 30, 2022 | 44.88 Mn |
| Jun 30, 2022 | 54.28 Mn |
| Mar 31, 2022 | 93.20 Mn |
| Dec 31, 2021 | 67.18 Mn |
| Sep 30, 2021 | 20.55 Mn |
| Jun 30, 2021 | 1.00 Mn |